EGF induces the expression of matrilysin in the human prostate adenocarcinoma cell line, LNCAP

Prostate

Volumn 40, Issue 3, 1999, Pages 159-166

  Sundareshan, Padma ^a,c   Nagle, Raymond B ^b   Bowden, G Tim ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c University of Arizona   (United States)

Author keywords

EGF; LNCaP; Matrilysin; mRNA stability; Prostate cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR; MATRILYSIN; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MESSENGER RNA SYNTHESIS; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; PROTEIN STABILITY; TRANSCRIPTION REGULATION;

ADENOCARCINOMA; DACTINOMYCIN; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MATRIX METALLOPROTEINASE 7; METALLOENDOPEPTIDASES; PROSTATIC NEOPLASMS; PROTEIN BIOSYNTHESIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0032807991     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19990801)40:3<159::AID-PROS3>3.0.CO;2-W     Document Type: Article

References (40)

1. Wilson CL, Matrisian LM. Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol 1996;28:123-136.
2. Gaire M, Magbanua Z, McDonnell S, McNeil L, Lovett DH, Matrisian LM. Structure and expression of the human gene for the matrix metalloproteinase matrilysin. J Biol Chem 1994;269: 2032-2040.
3. Rodgers WH, Osteen KG, Matrisian LM, Navre M, Giudice LC, Gorstein F. Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle. Am J Obstet Gynecol 1993;168:253-260.
4. Powell WC, Domann FE Jr, Mitchen JM, Matrisian LM, Nagle RB, Bowden GT. Matrilysin expression in the involuting rat ventral prostate. Prostate 1996;29:159-168.
5. Woessner JF Jr, Taplin CJ. Purification and properties of a small latent matrix metalloproteinase of the rat uterus. J Biol Chem 1988;263:16918-16925.
6. Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC, Chambon P. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 1990;348:699-704.
7. Muller D, Breathnach R, Engelmann A, Millon R, Bronner B, Flesch H, Dumont P, Eber M, Abecassis J. Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours. Int J Cancer 1991;48:550-556.
8. Karelina TV, Goldberg GI, Eisen AZ. Matrilysin (PUMP) correlates with dermal invasion during appendageal development and cutaneous neoplasia. J Invest Dermatol 1994;103:482-487.
9. Newell KJ, Witty JP, Rodgers WH, Matrisian LM. Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol Carcinog 1994;10:199-206.
10. McDonnell S, Navre M, Coffey RJ Jr, Matrisian LM. Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas. Mol Carcinog 1991; 4:527-533.
11. Pajouh MS, Nagle RB, Breathnach R, Finch JS, Brawer MK, Bowden GT. Expression of metalloproteinase genes in human prostate cancer. J Cancer Res Clin Oncol 1991;117:144-150.
12. Powell WC, Knox JD, Navre M, Grogan TM, Kittelson J, Nagle RB, Bowden GT. Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice. Cancer Res 1993;53:417-422.
13. McDonnell S, Wright JH, Gaire M, Matrisian LM. Expression and regulation of stromelysin and matrilysin by growth factors and oncogenes. Biochem Soc Trans 1994;22:58-62.
14. Matrisian LM, Hogan BLM. Role of growth factors in development. Curr Top Dev Biol 1990;24:219-259.
15. Gaire M, Barro CD, Kerr LD, Carlisle F, Matrisian LM. Protein kinase C isotypes required for phorbol-ester induction of stromelysin-1 in rat fibroblasts. Mol Carcinog 1996;15:124-133.
16. Marti H-P, McNeil L, Thomas G, Davies M, Lovett DH. Molecular characterization of a low-molecular-mass matrix metalloproteinase secreted by glomerular mesangial cells as PUMP-1. Biochem J 1992;285:899-905.
17. Yamamoto H, Itoh F, Senota A, Adachi Y, Yoshimoto M, Endoh T, Hinoda Y, Yachi A, Imai K. Expression of matrix metalloproteinase matrilysin (MMP-7) was induced by activated Ki-ras via AP-1 activation in SW1417 colon cancer cells. Clin Lab Anal 1995;9:297-301.
18. Sundareshan P, Koster JJ, Nagle RB, Bowden GT. Coordinated expression of matrilysin during TPA-induced apoptosis of LNCaP cells: two parallel processes affected by TPA. Cancer Lett 1997;113:17-24.
19. McKeehan WL, Adams PS, Fast D. Different hormonal requirements for androgen-independent growth of normal and tumor epithelial cells from rat prostate. In Vitro Cell Dev Biol 1987;23: 147-152.
20. Schuurmans ALG, Bolt J, Mulder E. Androgens and transforming growth factor β modulate the growth response to epidermal growth factor in human prostatic tumor cells (LNCaP). Mol Cell Endocrinol 1988;60:101-104.
21. Connolly JM, Rose DP. Production of epidermal growth factor and transforming growth factor-α by the androgen responsive LNCaP human prostate cancer cell line. Prostate 1990;16:209-218.
22. MacDonald A, Habib FK. Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines. Br J Cancer 1992;65:177-182.
23. Henttu P, Vihko P. Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP. Cancer Res 1993;53:1051-1058.
24. Wilding G, Zugmeier G, Knabbe C, Flanders K, Gelmann E. Differential effects of transforming beta on human prostate cancer cells in vitro. Mol Cell Endocrinol 1989;62:79-87.
25. Kim IY, Kim JH, Zelner DJ, Ahn HJ, Sensibar JA, Lee C. Transforming growth factor-betal is a mediator of androgen-regulated growth arrest in an androgen responsive prostatic cancer cell line, LNCaP. Endocrinology 1996;137:991-999.
26. Kim IY, Zelner DJ, Sensibar JA, Ahn HJ, Park L, Kim JH, Lee C. Modulation of sensitivity to transforming growth factor-betal (TGF-beta 1) and the level of type II TGF-beta receptor in LNCaP cells by dihydrotestosterone. Exp Cell Res 1996;222:103-110.
27. Morris GL, Dodd JG. Epidermal growth factor receptor mRNA levels in human prostatic tumors and cell lines. J Urol 1990;143: 1272-1274.
28. Wilding G, Valverius E, Knabbe C, Gelmann EP. Role of transforming growth factor-α in human prostate cancer cell growth. Prostate 1989;15:1-12.
29. Horchers AH, Powell MB, Fusenig NE, Bowden GT. Paracrine factor and cell-cell contact-mediated induction of protease and c-ets gene expression in malignant keratinocyte/dermal fibroblast cocultures. Exp Cell Res 1994;213:143-147.
30. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
31. Quantin B, Murphy G, Breathnach R. Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members. Biochemistry 1989;28:5327-5334.
32. Klein RD, Borchers AH, Sundareshan P, Bougelet C, Berkman MR, Nagle RB, Bowden GT. Interleukin-1β secreted from monocytic cells induces the expression of matrilysin in the prostatic cell line LNCaP. J Biol Chem 1997;272:14188-14192.
33. Sehgal I, Bailey J, Hitzemann K, Pittelkow MR, Maihle NJ. Epidermal growth factor receptor-dependent stimulation of amphiregulin expression in androgen-stimulated human prostate cancer cells. Mol Biol Cell 1994;5:339-347.
34. Borchers AH, Sanders LA, Bowden GT. Regulation of matrilysin expression in cells of squamous cell carcinoma by E-cadherin mediated cell cell contact. J Cancer Res Clin Oncol 1997;123:13-20.
35. Steiner MS. Role of peptide growth factors in the prostate: a review. Urology 1993;42:99-110.
36. Cunha GR, Alarid ET, Turner T, Donjacour AA, Boutin EL, Foster BA. Normal and abnormal development of the male urogenital tract: role of androgens, mesenchymal-epithelial interactions, and growth factors. J Androl 1992;13:465-475.
37. Truong LD, Kadmon D, McCune BK, Flanders KC, Scardino PT, Thompson TC. Association of transforming-growth factor-β1 with prostate cancer: a immunohistochemical study. Hum Pathol 1993;24:4-9.
38. Kim IY, Ahn HJ, Zelner DJ, Shaw JW, Sensibar JA, Kim JH, Kato M, Lee C. Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells. Cancer Res 1996;56: 44-48.
39. Guo YP, Kyprianou N. Overexpression of transforming growth factor (TGF) beta-1 type II receptor restores TGF-beta-1 sensitivity and signaling in human prostate cancer cells. Cell Growth Differ 1998;9:185-193.
40. Wallon UM, Shassetz LR, Cress AE, Bowden GT, Gerner EW. Polyamine-dependent expression of the matrix metalloproteinase matrilysin in a human colon cancer-derived cell line. Mol Carcinog 1994;11:138-144.